VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma

NCT04151615 · clinicaltrials.gov ↗
COMPLETED
Status
203
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Boryung Pharmaceutical Co., Ltd